Cargando…

Control of Intestinal Epithelial Permeability by Lysophosphatidic Acid Receptor 5

BACKGROUND & AIMS: Epithelial cells form a monolayer at mucosal surface that functions as a highly selective barrier. Lysophosphatidic acid (LPA) is a bioactive lipid that elicits a broad range of biological effects via cognate G protein-coupled receptors. LPA receptor 5 (LPA(5)) is highly expre...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Mo, He, Peijian, Han, Yiran, Dong, Lei, Yun, C. Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350072/
https://www.ncbi.nlm.nih.gov/pubmed/33975030
http://dx.doi.org/10.1016/j.jcmgh.2021.05.003
_version_ 1783735673786728448
author Wang, Mo
He, Peijian
Han, Yiran
Dong, Lei
Yun, C. Chris
author_facet Wang, Mo
He, Peijian
Han, Yiran
Dong, Lei
Yun, C. Chris
author_sort Wang, Mo
collection PubMed
description BACKGROUND & AIMS: Epithelial cells form a monolayer at mucosal surface that functions as a highly selective barrier. Lysophosphatidic acid (LPA) is a bioactive lipid that elicits a broad range of biological effects via cognate G protein-coupled receptors. LPA receptor 5 (LPA(5)) is highly expressed in intestinal epithelial cells, but its role in the intestine is not well-known. Here we determined the role of LPA(5) in regulation of intestinal epithelial barrier. METHODS: Epithelial barrier integrity was determined in mice with intestinal epithelial cell (IEC)-specific LPA(5) deletion, Lpar5(ΔIEC). LPA was orally administered to mice, and intestinal permeability was measured. Dextran sulfate sodium (DSS) was used to induce colitis. Human colonic epithelial cell lines were used to determine the LPA(5)-mediated signaling pathways that regulate epithelial barrier. RESULTS: We observed increased epithelial permeability in Lpar5(ΔIEC) mice with reduced claudin-4 expression. Oral administration of LPA decreased intestinal permeability in wild-type mice, but the effect was greatly mitigated in Lpar5(ΔIEC) mice. Serum lipopolysaccharide level and bacterial loads in the intestine and liver were elevated in Lpar5(ΔIEC) mice. Lpar5(ΔIEC) mice developed more severe colitis induced with DSS. LPA(5) transcriptionally regulated claudin-4, and this regulation was dependent on transactivation of the epidermal growth factor receptor, which induced localization of Rac1 at the cell membrane. LPA induced the translocation of Stat3 to the cell membrane and promoted the interaction between Rac1 and Stat3. Inhibition of Stat3 ablated LPA-mediated regulation of claudin-4. CONCLUSIONS: This study identifies LPA(5) as a regulator of the intestinal barrier. LPA(5) promotes claudin-4 expression in IECs through activation of Rac1 and Stat3.
format Online
Article
Text
id pubmed-8350072
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-83500722021-08-15 Control of Intestinal Epithelial Permeability by Lysophosphatidic Acid Receptor 5 Wang, Mo He, Peijian Han, Yiran Dong, Lei Yun, C. Chris Cell Mol Gastroenterol Hepatol Original Research BACKGROUND & AIMS: Epithelial cells form a monolayer at mucosal surface that functions as a highly selective barrier. Lysophosphatidic acid (LPA) is a bioactive lipid that elicits a broad range of biological effects via cognate G protein-coupled receptors. LPA receptor 5 (LPA(5)) is highly expressed in intestinal epithelial cells, but its role in the intestine is not well-known. Here we determined the role of LPA(5) in regulation of intestinal epithelial barrier. METHODS: Epithelial barrier integrity was determined in mice with intestinal epithelial cell (IEC)-specific LPA(5) deletion, Lpar5(ΔIEC). LPA was orally administered to mice, and intestinal permeability was measured. Dextran sulfate sodium (DSS) was used to induce colitis. Human colonic epithelial cell lines were used to determine the LPA(5)-mediated signaling pathways that regulate epithelial barrier. RESULTS: We observed increased epithelial permeability in Lpar5(ΔIEC) mice with reduced claudin-4 expression. Oral administration of LPA decreased intestinal permeability in wild-type mice, but the effect was greatly mitigated in Lpar5(ΔIEC) mice. Serum lipopolysaccharide level and bacterial loads in the intestine and liver were elevated in Lpar5(ΔIEC) mice. Lpar5(ΔIEC) mice developed more severe colitis induced with DSS. LPA(5) transcriptionally regulated claudin-4, and this regulation was dependent on transactivation of the epidermal growth factor receptor, which induced localization of Rac1 at the cell membrane. LPA induced the translocation of Stat3 to the cell membrane and promoted the interaction between Rac1 and Stat3. Inhibition of Stat3 ablated LPA-mediated regulation of claudin-4. CONCLUSIONS: This study identifies LPA(5) as a regulator of the intestinal barrier. LPA(5) promotes claudin-4 expression in IECs through activation of Rac1 and Stat3. Elsevier 2021-05-08 /pmc/articles/PMC8350072/ /pubmed/33975030 http://dx.doi.org/10.1016/j.jcmgh.2021.05.003 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research
Wang, Mo
He, Peijian
Han, Yiran
Dong, Lei
Yun, C. Chris
Control of Intestinal Epithelial Permeability by Lysophosphatidic Acid Receptor 5
title Control of Intestinal Epithelial Permeability by Lysophosphatidic Acid Receptor 5
title_full Control of Intestinal Epithelial Permeability by Lysophosphatidic Acid Receptor 5
title_fullStr Control of Intestinal Epithelial Permeability by Lysophosphatidic Acid Receptor 5
title_full_unstemmed Control of Intestinal Epithelial Permeability by Lysophosphatidic Acid Receptor 5
title_short Control of Intestinal Epithelial Permeability by Lysophosphatidic Acid Receptor 5
title_sort control of intestinal epithelial permeability by lysophosphatidic acid receptor 5
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350072/
https://www.ncbi.nlm.nih.gov/pubmed/33975030
http://dx.doi.org/10.1016/j.jcmgh.2021.05.003
work_keys_str_mv AT wangmo controlofintestinalepithelialpermeabilitybylysophosphatidicacidreceptor5
AT hepeijian controlofintestinalepithelialpermeabilitybylysophosphatidicacidreceptor5
AT hanyiran controlofintestinalepithelialpermeabilitybylysophosphatidicacidreceptor5
AT donglei controlofintestinalepithelialpermeabilitybylysophosphatidicacidreceptor5
AT yuncchris controlofintestinalepithelialpermeabilitybylysophosphatidicacidreceptor5